Six-month prevalence of psychiatric disorders in three communities 1980 to 1982

Archives of General Psychiatry
J K MyersM Kramer

Abstract

Six-month prevalence rates for selected DSM-III psychiatric disorders are reported based on community surveys in New Haven, Conn, Baltimore, and St Louis. As part of the Epidemiologic Catchment Area program, data were gathered on more than 9,000 adults, employing the Diagnostic Interview Schedule to collect information to make a diagnosis. The most common disorders found were phobias, alcohol abuse and/or dependence, dysthymia, and major depression. The most common diagnoses for women were phobias and major depression, whereas for men, the most predominant disorder was alcohol abuse and/or dependence. Rates of psychiatric disorders dropped sharply after age 45 years.

Citations

May 19, 2007·Psychosomatic Medicine·Walter J MeyerCharles E Holzer
Sep 3, 2010·European Journal of Endocrinology·Sven C MuellerDeborah P Merke
Dec 1, 1991·Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·B Fernandez-PolM S Muzruchi
Jun 1, 1994·Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·C B Brenneis
Dec 30, 2009·Journal of Autism and Developmental Disorders·Gideon E AnholtAnton J L M van Balkom
Apr 18, 1998·Journal of Affective Disorders·B W PalmerJ I Sheikh
Dec 16, 1996·Journal of Affective Disorders·N van den HeuvelA T Beekman
Aug 18, 1995·Journal of Affective Disorders·D M GirlingF A Huppert
Oct 26, 2000·Clinical Therapeutics·P N TariotI W Rak
Jul 1, 1991·Journal of General Internal Medicine·D G SimonM Moore
Sep 1, 1994·Journal of General Internal Medicine·P Roy-ByrneM Liebowitz
Nov 1, 1989·Journal of General Internal Medicine·J L CoulehanM R Block
Mar 1, 1990·Journal of General Internal Medicine·R Lavizzo-MoureyR V Sims
Jun 1, 1989·American Journal of Public Health·M L Bruce, P J Leaf
May 1, 1988·American Journal of Public Health·J M MurphyA H Leighton
Jul 1, 1987·American Journal of Public Health·J I EscobarK B Wells
Apr 1, 1987·American Journal of Public Health·M M Weissman
May 1, 1985·American Journal of Public Health·W A VegaG Warheit
Jan 1, 1987·American Journal of Public Health·L G KesslerR H Miller
Jun 1, 1993·American Journal of Public Health·R M CrumJ C Anthony
Jun 6, 1998·BMJ : British Medical Journal·B Pitt
Sep 22, 1999·Journal of General Internal Medicine·L S GoldmanH C Champion
Feb 16, 2006·The Australian and New Zealand Journal of Psychiatry·David J Castle, Katharine A Phillips
Apr 18, 2009·Harvard Review of Psychiatry·Veronica HarshPeter J Schmidt
Jun 30, 2009·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Mauro Giovanni CartaMaria Carolina Hardoy
Aug 11, 2011·Journal of Pharmacy & Bioallied Sciences·Nidhi MaheshwariNirender Pal Singh
Mar 19, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H Plein, M Berk
Dec 24, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·G InvernizziL Waintraub
Jun 1, 1988·Journal of Cross-cultural Gerontology·L K SyryaniG D Jensen
Feb 1, 1995·Controlled Clinical Trials·M S KamletM Wade
Jan 1, 1986·Social Psychiatry. Sozialpsychiatrie. Psychiatrie Sociale·I M Marks
May 13, 2005·Rheumatology International·A S Russell, B K Hui
Jan 1, 1993·Journal of Substance Abuse Treatment·P G O'ConnorS R Segal
Jan 1, 1990·Journal of Substance Abuse Treatment·M HansonW Gross
Oct 9, 2002·Journal of the American Geriatrics Society·Arlene FinkAlison A Moore
Jun 23, 1999·Progress in Neuro-psychopharmacology & Biological Psychiatry·A Papassotiropoulos, R Heun
Jun 1, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·I AbenM Maes
Jan 1, 1994·Anxiety·E A MartinsB Dubbert
Jan 1, 1994·Anxiety·G PerugiD M McNair
Jan 1, 1990·Psychological Medicine. Monograph Supplement·P Duncan-JonesL J Horwood
Feb 1, 1994·Psychological Medicine·K Wilhelm, G Parker

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.